Shared articles for:

Jeanine Walenga

Jeffrey Schwartz

  • Identification of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients Implanted With a Continuous-Flow Left Ventricular Assist Device
    Journal Article

    McClane, N.; Jeske, W; Walenga, J. M.; Escalante, V; Hoppensteadt, D; more...
    Clinical Applied Thrombosis/Hemostasis (2018)

    Find It @ Loyola | Save
  • Blood cell microparticles as biomarkers of hemostatic abnormalities in patients with implanted cardiac assist devices
    Journal Article

    Jeske, W. P.; Walenga, J. M.; Menapace, B.; Schwartz, J; Bakhos, M
    Biomarkers in medicine (2016)

    Find It @ Loyola | Save
  • Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimen
    Journal Article

    Ashbrook, M.; Walenga, J. M.; Schwartz, J; Heroux, A.; Jeske, W. P.; more...
    Clinical Applied Thrombosis/Hemostasis (2013)

    Find It @ Loyola | Save